Company registration number SC216440 (Scotland)
CALEDONIAN BIOSYSTEM LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
CALEDONIAN BIOSYSTEM LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
CALEDONIAN BIOSYSTEM LIMITED
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Cash at bank and in hand
1,377
1,377
Creditors: amounts falling due within one year
3
(1)
(1)
Net current assets
1,376
1,376
Capital and reserves
Called up share capital
4
99
99
Profit and loss reserves
1,277
1,277
Total equity
1,376
1,376

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 14 June 2024 and are signed on its behalf by:
Mr G Fleming
Director
Company Registration No. SC216440
CALEDONIAN BIOSYSTEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 2 -
1
Accounting policies
Company information

Caledonian Biosystem Limited is a private company limited by shares incorporated in Scotland. The registered office is 5 Atholl Avenue, Hillington, Glasgow, United Kingdom, G52 4UA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
-
0
-
0
3
Creditors: amounts falling due within one year
2024
2023
£
£
Other creditors
1
1
4
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
99
99
99
99
2024-03-312023-04-01false14 June 2024CCH SoftwareCCH Accounts Production 2024.100No description of principal activityMr A ThorntonMr G FlemingMr G FlemingfalsefalseSC2164402023-04-012024-03-31SC2164402024-03-31SC2164402023-03-31SC216440core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-31SC216440core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-31SC216440core:ShareCapital2024-03-31SC216440core:ShareCapital2023-03-31SC216440core:RetainedEarningsAccumulatedLosses2024-03-31SC216440core:RetainedEarningsAccumulatedLosses2023-03-31SC216440bus:CompanySecretaryDirector12023-04-012024-03-31SC2164402022-04-012023-03-31SC216440core:CurrentFinancialInstruments2024-03-31SC216440core:CurrentFinancialInstruments2023-03-31SC216440bus:PrivateLimitedCompanyLtd2023-04-012024-03-31SC216440bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-31SC216440bus:FRS1022023-04-012024-03-31SC216440bus:AuditExemptWithAccountantsReport2023-04-012024-03-31SC216440bus:Director12023-04-012024-03-31SC216440bus:Director22023-04-012024-03-31SC216440bus:CompanySecretary12023-04-012024-03-31SC216440bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP